4-(6,8-Dibromo-3(4H)-quinazolinyl)cyclohexanol
2,4-dibromo-6-((cyclohexyl(methyl)amino)methyl)aniline hydrobromide is listed by Simson Pharma as a metabolites for laboratory research, analytical development and quality-control workflows.
Suitability is method- and purpose-specific. Before use, verify the product name, catalogue number, chemical identifiers, storage requirements and the information reported in the current product or batch documentation. Your laboratory remains responsible for method qualification or validation.
2,4-dibromo-6-((cyclohexyl(methyl)amino)methyl)aniline hydrobromide for method validation 2,4-dibromo-6-((cyclohexyl(methyl)amino)methyl)aniline hydrobromide reference standard 2,4-dibromo-6-((cyclohexyl(methyl)amino)methyl)aniline hydrobromide for ANDA filing 2,4-dibromo-6-((cyclohexyl(methyl)amino)methyl)aniline hydrobromide for forced degradation studies 2,4-dibromo-6-((cyclohexyl(methyl)amino)methyl)aniline hydrobromide identification standard 2,4-dibromo-6-((cyclohexyl(methyl)amino)methyl)aniline hydrobromide for DMF filing 2,4-dibromo-6-((cyclohexyl(methyl)amino)methyl)aniline hydrobromide HPLC standard 2,4-dibromo-6-((cyclohexyl(methyl)amino)methyl)aniline hydrobromide supplier 2,4-dibromo-6-((cyclohexyl(methyl)amino)methyl)aniline hydrobromide manufacturer 2,4-dibromo-6-((cyclohexyl(methyl)amino)methyl)aniline hydrobromide distributor
